Epilepsy Currents

Journal

Publication Venue For

  • 2014 epilepsy Benchmarks Area III: Improve treatment options for controlling seizures and epilepsy-related conditions without side effects.  16:192-197.
  • A gut feeling about seizures.  18:389-390.
  • A “Sodium Drug” for Generalized Epilepsy? A Mystery That Still Needs to be Solved.  21:326-328.
  • AEDs and Cognition: One Small Fish in a Very Large Pond?.  20:196-198.
  • Analysis of Blood DNA Methylation in Early-Life Seizures.  20:393-395.
  • Are idiopathic generalized epilepsies focal?.  16:242-244.
  • Cold but not dead: The role of EEG in predicting the outcome after cardiac arrest.  16:389-390.
  • Connectomics 2.0: Connected or not, is this the question.  17:155-156.
  • Epigenetic Therapeutic Intervention for a Rare Epilepsy Disorder.  20:111-112.
  • Epilepsy and Neurodegeneration: A Bidirectional Relationship.  21:102-104.
  • Epileptogenesis: Can the science of epigenetics give us answers?.  12:105-110.
  • Expeditions in epidemiologic studies of new onset epilepsy in older adults: Stake your claims.  17:368-369.
  • Is fMRI Ready to Replace IAP? Wait, Wait,…We Are Not There Yet!.  20:6S-8S.
  • Is there equipoise between phenytoin and levetiracetam for seizure prevention in traumatic brain injury?.  15:94-97.
  • Magnetoencephalography and stereo-EEG unite!.  17:86-87.
  • Not a Slam-Dunk: Assessing the Role of EEG/fMRI in the Presurgical Evaluation.  22:100-102.
  • Overcoming barriers to successful epilepsy management.  12:158-160.
  • Psychogenic Nonepileptic Seizures (PNES) as a network disorder - Evidence from neuroimaging of functional (psychogenic) neurological disorders.  18:211-216.
  • Regulation of circuits and excitability: implications for epileptogenesis..  4:151-153.
  • Seizing the Neuroinflammatory Target: The Quest Continues.  19:379-381.
  • Sleep and epilepsy: A summary of the 2011 merritt-putnam symposium.  13:42-49.
  • Thalamus and Seizures—Here We Come Again….  21:154-156.
  • The 'thalamic hubness' of anterior temporal lobectomy outcome.  17:283-284.
  • The Dilemma of the Chicken or the Egg—What Appears First in TLE—Seizures or Morphometric Changes in the Temporal Lobe?.  19:101-102.
  • The Molecular Dichotomy Between Epileptic and Functional Seizures.  21:258-260.
  • The disruptive nature of focal developmental insults.  18:29-30.
  • The highs and lows of the endocannabinoid system—Another piece to the epilepsy puzzle?.  18:315-317.
  • The man versus the machine: The machine wins the race to detect the scalp-negative seizures.  17:142-143.
  • Toward the "fingerprint" of the ictal onset zone - Is Mr. Morlet the winner?.  18:158-159.
  • Treatment of Super-Refractory Status Epilepticus: A Review.  21:405-415.
  • Understanding memory systems in TLE: Networks, nodes, and hubs.  16:153-155.
  • What should we prescribe for acute seizures when there is no intravenous access?.  16:135-136.
  • fMRI Language Activation—If You See It Don’t Resect It….  19:240-242.
  • the burden of normality in the epilepsy postsurgery setting: out with the old and in with the new (...roles).  16:375-377.

    • International Standard Serial Number (issn)

  • 1535-7597